Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer

DSC3 expression is regulated by p53 and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer

(2011) T Cui et al.   BRITISH JOURNAL OF CANCER

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Reduced expression of desmocollin 2 is an independent prognostic biomarker for shorter patients survival in pancreatic ductal adenocarcinoma

(2011) Z. Hamidov et al.   JOURNAL OF CLINICAL PATHOLOGY

Desmosomes: adhesive strength and signalling in health and disease

(2010) Helen A. Thomason et al.   BIOCHEMICAL JOURNAL

Metastatic pancreatic cancer: Is gemcitabine still the best standard treatment? (Review)

(2010) Di Marco   ONCOLOGY REPORTS

Loss of the p53/p63 Regulated Desmosomal Protein Perp Promotes Tumorigenesis

(2010) Veronica G. Beaudry et al.   PLoS Genetics

Genetic Deletion of the Desmosomal Component Desmoplakin Promotes Tumor Microinvasion in a Mouse Model of Pancreatic Neuroendocrine Carcinogenesis

(2010) Matthew G. H. Chun et al.   PLoS Genetics

Altered desmoplakin expression at transcriptional and protein levels provides prognostic information in human oropharyngeal cancer

(2009) Silvana Papagerakis et al.   HUMAN PATHOLOGY

Upregulation of plakophilin-2 and its acquisition to adherens junctions identifies a novel molecular ensemble of cell-cell-attachment characteristic for transformed mesenchymal cells

(2009) Steffen Rickelt et al.   INTERNATIONAL JOURNAL OF CANCER

The Desmosome

(2009) E. Delva et al.   Cold Spring Harbor Perspectives in Biology

Desmosome structure, composition and function

(2007) David Garrod et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Role of gemcitabine in metastatic breast cancer patients: A short review

(2007) Nicola Silvestris et al.   BREAST